Abbott Says Spinal Cord Stimulator Injury Cases Do Not Warrant Centralization
WASHINGTON, D.C. — Abbott Laboratories urges the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) to reject a renewed effort by individuals who allege that they were injured by defective spinal cord...To view the full article, register now.
Already a subscriber? Click here to view full article